References
Albagha OM,
Visconti MR,
Alonso N et al.
(2010)
Genome‐wide association study identifies variants at CSF1, OPTN and TNFRSF11A as genetic risk factors for Paget's disease of bone.
Nature Genetics
42(6):
520–524.
Albagha OM,
Visconti MR,
Alonso N et al.
(2013)
Common susceptibility alleles and SQSTM1 mutations predict disease extent and severity in a multinational study of patients with Paget's disease.
Journal of Bone and Mineral Research
28(11):
2338–2346.
Albagha OM,
Wani SE,
Visconti MR et al.
(2011)
Genetic Determinants of Paget's Disease (GDPD) Consortium. Genome‐wide association identifies three new susceptibility loci for Paget's disease of bone.
Nature Genetics
43(7):
685–689.
Beauregard M,
Gagnon E,
Guay‐Bélanger S et al.
(2013)
Genetic association study of Dickkopf‐1 and sclerostin genes with Paget disease of bone.
Calcified Tissue International
93(5):
405–412.
Bolland MJ,
Tong PC,
Naot D et al.
(2007)
Delayed development of Paget's disease in offspring inheriting SQSTM1 mutations.
Journal of Bone and Mineral Research
22(3):
411−415.
Chung PY,
Beyens G,
de Freitas F et al.
(2011)
Indications for a genetic association of a VCP polymorphism with the pathogenesis of sporadic Paget's disease of bone, but not for TNFSF11 (RANKL) and IL‐6 polymorphisms.
Molecular Genetics and Metabolism
103(3):
287–292.
Chung PY,
Beyens G,
Riches PL et al.
(2010)
Genetic variation in the TNFRSF11A gene encoding RANK is associated with susceptibility to Paget's disease of bone.
Journal of Bone and Mineral Research
25(12):
2316–2329.
Chung PY and
Van Hul W
(2012)
Paget's disease of bone: evidence for complex pathogenetic interactions.
Seminars in Arthritis and Rheumatism
41(5):
619–641.
Cooper C,
Harvey NC,
Dennison EM and
van Staa TP
(2006)
Update on the epidemiology of Paget's disease of bone.
Journal of Bone and Mineral Research
21(suppl. 2):
P3–P8.
Corral‐Gudino L,
del Pino‐Montes J,
García‐Aparicio J et al.
(2006)
-511 C/T IL1B gene polymorphism is associated to resistance to bisphosphonates treatment in Paget disease of bone.
Bone
38(4):
589–594.
Corral‐Gudino L,
del Pino‐Montes J,
García‐Aparicio J,
Alonso‐Garrido M and
González-Sarmiento R
(2010)
Paget's disease of bone is not associated with common polymorphisms in interleukin-6, interleukin-8 and tumor necrosis factor alpha genes.
Cytokine
52(3):
146–150.
Cundy T,
Hegde M,
Naot D et al.
(2002)
A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype.
Human Molecular Genetics
11(18):
2119–2127.
Daroszewska A,
Hocking LJ,
McGuigan FE et al.
(2004)
Susceptibility to Paget's disease of bone is influenced by a common polymorphic variant of osteoprotegerin.
Journal of Bone and Mineral Research
19(9):
1506–1511.
Daroszewska A,
van't Hof RJ,
Rojas JA et al.
(2011)
A point mutation in the ubiquitin‐associated domain of SQSMT1 is sufficient to cause a Paget's disease‐like disorder in mice.
Human Molecular Genetics
20(14):
2734–2744.
Donath J,
Speer G,
Poor G et al.
(2004)
Vitamin D receptor, oestrogen receptor‐alpha and calcium‐sensing receptor genotypes, bone mineral density and biochemical markers in Paget's disease of bone.
Rheumatology
43(6):
692–695.
Garner TP,
Long J,
Layfield R and
Searle MS
(2011)
Impact of p62/SQSTM1 UBA domain mutations linked to Paget's disease of bone on ubiquitin recognition.
Biochemistry
50(21):
4665–4674.
Geetha T,
Vishwaprakash N,
Sycheva M and
Babu JR
(2012)
Sequestosome 1/p62: across diseases.
Biomarkers
17(2):
99–103.
Gennari L,
De Paola V,
Merlotti D,
Martini G and
Nuti R
(2008)
Genetic predisposition to Paget disease of bone.
In: Louane BE and
Maëlys LB (eds)
Genetic Predisposition to Disease: New Research,
chap. 1,
Hauppauge, NY: Nova Science Publishers, Inc.
Gennari L,
Gianfrancesco F,
Di Stefano M et al.
(2010)
SQSTM1 gene analysis and gene‐environment interaction in Paget's disease of bone.
Journal of Bone and Mineral Research
25(6):
1375–1384.
Gianfrancesco F,
Rendina D,
Di Stefano M et al.
(2012)
A nonsynonymous TNFRSF11A variation increases NFκB activity and the severity of Paget's disease.
Journal of Bone and Mineral Research
27(2):
443–452.
Goode A,
Long JE,
Shaw B et al.
(2014)
Paget disease of bone‐associated UBA domain mutations of SQSTM1 exert distinct effects on protein structure and function.
Biochim Biophys Acta:
1842(7):
992–1000.
Hansen MF,
Seton M and
Merchant A
(2006)
Osteosarcoma in Paget's disease of bone.
Journal of Bone and Mineral Research
21(suppl. 2):
P58–P63.
Hiruma Y,
Kurihara N,
Subler MA et al.
(2008)
A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment.
Human Molecular Genetics
17(23):
3708–3719.
Hocking LJ,
Lucas GJ,
Daroszewska A et al.
(2002)
Domain specific mutations in Sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease.
Human Molecular Genetics
11(22):
2735–2739.
Hughes AE,
Shearman AM,
Weber JL et al.
(1994)
Genetic linkage of familial expansile osteolysis to chromosome 18q.
Human Molecular Genetics
3(2):
359–361.
Hughes AE,
Ralston SH,
Marken J et al.
(2000)
Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis.
Nature Genetics
24(1):
45–48.
Jacobs TP,
Michelsen J,
Polay JS et al.
(1979)
Giant cell tumor in Paget's disease of bone: familial and geographic clustering.
Cancer
44(2):
742–747.
Kanis JA
(1998)
Pathophysiology and Treatment of Paget's Disease of Bone,
2nd edn, chap. 10.
London: Martin Dunitz.
Ke YH,
Yue H,
He JW,
Liu YJ and
Zhang ZL
(2009)
Early onset Paget's disease of bone caused by a novel mutation (78dup27) of the TNFRSF11A gene in a Chinese family.
Acta Pharmacologica Sinica
30(8):
1204–1210.
Kovach M,
Waggoner B,
Leal SM et al.
(2001)
Clinical delineation and localization to chromosome 9p13.3‐p12 of a unique dominant disorder in four families: hereditary inclusion body myopathy, Paget's disease of bone, and frontotemporal dementia.
Molecular Genetics and Metabolism
74(4):
458–475.
Kurihara N,
Zhou H,
Reddy SV et al.
(2006)
Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease like bone lesions in mice.
Journal of Bone and Mineral Research
21(3):
446–455.
Kurihara N,
Hiruma Y,
Zhou H et al.
(2007)
Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease.
Journal of Clinical Investigation
117(1):
133–142.
Kurihara N,
Hiruma Y,
Yamana K et al.
(2011)
Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease.
Cell Metabolism
13(1):
23–34.
Laurin N,
Brown JP,
Morissette J and
Raymond V
(2002)
Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone.
American Journal of Human Genetics
70(6):
1582–1588.
Leach RJ,
Singer FR,
Ench Y et al.
(2006)
Clinical and cellular phenotypes associated with sequestosome 1 (SQSTM1) mutations.
Journal of Bone and Mineral Research
21(suppl. 2):
P45–P50.
Lucas GJ,
Mehta SG,
Hocking LJ et al.
(2006)
Evaluation of the role of Valosin‐containing protein in the pathogenesis of familial and sporadic Paget's disease of bone.
Bone
8(2):
280–285.
Mehta SG,
Watts GD,
Adamson JL et al.
(2007)
APOE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia (IBMPFD).
Genetics in Medicine
9(1):
9–13.
Michou L,
Conceição N,
Morissette J et al.
(2012)
Genetic association study of UCMA/GRP and OPTN genes (PDB6 locus) with Paget's disease of bone.
Bone
51(4):
720–728.
Morales‐Piga AA,
Rey‐Rey JS,
Corres‐Gonzalez J,
Garcia‐Sagredo JM and
Lopez‐Abente G
(1995)
Frequency and characteristics of familial aggregation of Paget's disease of bone.
Journal of Bone and Mineral Research
10(4):
663–670.
Nakatsuka K,
Nishizawa Y and
Ralston SH
(2003)
Phenotypic characterization of early onset Paget's disease of bone caused by a 27‐bp duplication in the TNFRSF11A gene.
Journal of Bone and Mineral Research
18(8):
1381–1385.
Osterberg PH,
Wallace RG,
Adams DA et al.
(1988)
Familial expansile osteolysis. A new dysplasia.
Journal of Bone & Joint Surgery (British Volume)
70(2):
255–260.
Ralston SH
(2008)
Juvenile Paget's disease, familial expansile osteolysis and other genetic osteolytic disorders.
Best Practice & Research Clinical Rheumatology
22(1):
101–111.
Ralston SH and
Layfield R
(2012)
Pathogenesis of Paget disease of bone.
Calcified Tissue International
91(2):
97–113.
Ralston SH
(2013)
Paget's disease of bone.
New England Journal of Medicine
368(7):
644–650.
Rea SL,
Walsh JP,
Ward L et al.
(2006)
A novel mutation (K378X) in the sequestosome 1 gene associated with increased NF‐kappaB signalling and Paget's disease of bone with a severe phenotype.
Journal of Bone and Mineral Research
21(7):
1136–1145.
Rea SL,
Walsh JP,
Layfield R,
Ratajczak T and
Xu J
(2013)
New insights into the role of sequestosome 1/p62 mutant proteins in the pathogenesis of Paget's disease of bone.
Endocrine Reviews
34(4):
501–524.
Rea SL,
Majcher V,
Searle MS and
Layfield R
(2014)
SQSTM1 mutations – bridging Paget disease of bone and ALS/FTLD.
Experimental Cell Research,
pii: S0014‐4827(14)00040‐00048.
doi:10.1016/j.yexcr.2014.01.020. [Epub ahead of print].
Reddy SV,
Menaa C,
Singer FR,
Demulder A and
Roodman GD
(1999)
Cell biology of Paget disease.
Journal of Bone and Mineral Research
14(suppl. 2):
3–8
Roodman GD and
Windle JJ
(2005)
Paget disease of bone.
Journal of Clinical Investigation
115(2):
200–208.
Singer FR
(2011)
The etiology of Paget's disease of bone: viral and genetic interactions.
Cell Metabolism
13(1):
5–6.
Siris ES,
Ottman R,
Flaster E and
Kelsey JL
(1991)
Familial aggregation of Paget's disease of bone.
Journal of Bone and Mineral Research
6(5):
495–500.
Sundaram K,
Shanmugarajan S,
Rao DS and
Reddy SV
(2011)
Mutant p62P392L stimulation of osteoclast differentiation in Paget's disease of bone.
Endocrinology
152(11):
4180–4189.
Visconti MR,
Langston AL,
Alonso N et al.
(2010)
Mutations of SQSTM1 are associated with severity and clinical outcome in Paget's disease of bone.
Journal of Bone and Mineral Research
25(11):
2368–2373.
Watts GD,
Wymer J,
Kovach MJ et al.
(2004)
Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin‐containing protein.
Nature Genetics
36(4):
377–381.
Whyte MP,
Obrecht SE,
Finnegan PM et al.
(2002)
Osteoprotegerin deficiency and juvenile Paget's disease.
New England Journal of Medicine
347(3):
175–184.
Whyte MP and
Hughes AE
(2002)
Expansile skeletal hyperphosphatasia is caused by a 15‐base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis.
Journal of Bone and Mineral Research
17(1):
26–29.
Wuyts W,
Van Wesenbeeck L,
Morales‐Piga A et al.
(2001)
Evaluation of the role of RANK and OPG genes in Paget's disease of bone.
Bone
28(1):
104–107.
Zhong X,
Shen Y,
Ballar P et al.
(2004)
AAA ATPase p97/valosin‐containing protein interacts with gp78, a ubiquitin ligase for endoplasmic reticulum‐associated degradation.
Journal of Biological Chemistry
279(44):
45676–45684.
Further Reading
Beyens G,
Daroszewska A,
de Freitas F et al.
(2007)
Identification of sex‐specific associations between polymorphisms of the osteoprotegerin gene TNFRSF11B, and Paget's disease of bone.
Journal of Bone and Mineral Research
22(7):
1062–1071.
Gianfrancesco F,
Rendina D,
Merlotti D et al.
(2013)
Giant cell tumor occurring in familial Paget's disease of bone: report of clinical characteristics and linkage analysis of a large pedigree.
Journal of Bone and Mineral Research
28(2):
341–350.
Paget J
(1877)
On a form of chronic inflammation of bones (osteitis deformans).
Medico‐Chirurgical Transactions
60:
37–63.
Ralston SH,
Langston AL and
Reid IR
(2008)
Pathogenesis and management of Paget's disease of bone.
Lancet
372(9633):
155–163.
Zhu G,
Wu CJ,
Zhao Y and
Ashwell JD
(2007)
Optineurin negatively regulates TNFalpha‐ induced NF‐kappaB activation by competing with NEMO for ubiquitinated RIP.
Current Biology
17(16):
1438–1443.